CG Oncology, Inc.(CGON)Earnings Date, History & Expected Move

Next report
Not scheduled

CGON has no upcoming report date in the calendar yet. It last reported on Nov 6, 2026; companies usually report every three months.

Next report
Not scheduled
Last reported Nov 6, 2026
EPS beat rate
33%
4 of 12 quarters
Avg move after earnings
±5.7%
Up 73% of the time · last 11
Options-implied move
—
No reliable options quote yet

EPS: Actual vs Estimate

Reported EPS against the consensus estimate, last 12 quarters.

Green beat or met, red missed, amber sources differ.

Stock Reaction After Earnings

Close-to-close move in the first session that reflected each report.

Dashed lines mark the average actual move (±5.7%).

Did the stock rise after good news?

The next-day move after each of its last 4 EPS beats and 7 misses.

When it beat expectations
4 reports
When it missed expectations
7 reports

In plain words: it beat expectations 4 times, but the stock still fell 1 of those 4 times.

Report by report
  • Nov '26
    Beat
    ▲ +17.3%
  • Aug '26
    Missed
    ▲ +3.4%
  • May '26
    Missed
    ▲ +0.6%
  • Feb '26
    Beat
    ▲ +4.8%
  • Nov '25
    Missed
    ▲ +8.6%
  • Aug '25
    Missed
    ▲ +2.1%
  • May '25
    Missed
    ▼ -3.9%
  • Nov '24
    Beat
    ▼ -6.8%
  • Aug '24
    Beat
    ▲ +7.0%
  • May '24
    Missed
    ▼ -7.4%
  • Mar '24
    Missed
    ▲ +0.3%

Clear beats and misses with a known reaction only. What counts as a beat

After an EPS beat
+5.6%
average next-day move · up 75% of 4 times
After an EPS miss
+0.5%
average next-day move · up 71% of 7 times

Why did CGON fall after beating earnings?

6 of CGON's last 11 reactions went against the EPS result. What stands out in each:

CGON beat EPS estimates in 4 quarters, and the stock still closed lower the next day 1 time.

  • Nov 12, 2024EPS beat +11.8%stock -6.8% next day
    • It had risen 5.8% in the 20 trading sessions before the report, so good news may already have been priced in.

Rose despite an EPS miss (5 of 7)

  • Aug 6, 2026EPS missed -40.6%stock +3.4% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • May 8, 2026EPS missed -31.5%stock +0.6% next day

    Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.

  • Nov 14, 2025EPS missed -3.6%stock +8.6% next day
    • It had already fallen 9.8% in the 20 trading sessions before the report, so weak results may have been expected.
  • Aug 8, 2025EPS missed -20.0%stock +2.1% next day
    • It had already fallen 10.2% in the 20 trading sessions before the report, so weak results may have been expected.
  • Mar 26, 2024EPS missed -1342.0%stock +0.3% next day
    • It had already fallen 11.4% in the 20 trading sessions before the report, so weak results may have been expected.

Patterns in estimates and prices, not confirmed causes: how we read them.

Was CGON's earnings move already priced in?

CGON's move in the month before each of its last 11 reports, against what it did after.

Avg move in the month before
-0.4%
last 11 reports
Higher before the report
55%
of the time
After a run-up of 3%+
Fell 50%
4 reports, avg -0.6%
After a drop of 3%+
Rose 80%
5 reports, avg +2.1%

How the run-up is measured (a move of 5% or more counts as large).

Before vs after each report

Grey: the month before each of the last 11 reports. Green or red: the day after.

Past reports only. How the run-up is measured

CGON earnings history

Last 12 reported quarters with the stock's reaction.

Swipe sideways to see every column →

Report dateTimeEPS est.EPS actualSurpriseRevenue surprise1-day move3-day move
Nov 6, 2026Before open-$0.81-$0.64+21.0%+225.9%+17.27%—
Aug 6, 2026Before open-$0.64-$0.90-40.6%—+3.36%+5.72%
May 8, 2026Before open-$0.54-$0.71-31.5%—+0.64%+4.18%
Feb 27, 2026Before open-$0.58-$0.51+12.1%—+4.79%+7.91%
Nov 14, 2025Before open-$0.55-$0.57-3.6%—+8.61%+12.69%
Aug 8, 2025Before open-$0.45-$0.54-20.0%—+2.05%+2.46%
May 13, 2025Before open-$0.37-$0.45-21.6%—-3.90%+0.76%
Mar 28, 2025Before open-$0.46-$0.48-4.3%———
Nov 12, 2024Before open-$0.34-$0.30+11.8%—-6.83%-10.56%
Aug 8, 2024Before open-$0.31-$0.28+9.7%—+7.02%+5.92%
May 9, 2024Before open-$0.15-$0.36-140.0%—-7.43%-20.32%
Mar 26, 2024Before open-$1.00-$14.42-1342.0%—+0.27%+7.70%

CGON Earnings FAQ

Answers computed from CG Oncology, Inc.'s reported history

CGON has no upcoming report date in the calendar yet. It last reported on Nov 6, 2026; companies usually report every three months.

Over the last 12 quarters with a usable EPS surprise, CGON beat the consensus estimate 4 times (33%), missed 8 and landed in line 0.

Across its last 11 quarters with a measured reaction, CGON moved an average of ±5.7% in the first session after reporting. It closed higher 73% of the time; the largest gain was 17.3% and the largest drop -7.4%.

CGON fell in the first session after 1 of its last 4 EPS beats (25%). A beat that was already priced in, or weaker guidance, can send a stock lower.

Across its last 11 quarters with price data, CGON moved an average of -0.4% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (4 quarters), it fell the next day 50% of the time, averaging -0.6%. After a drop of 3% or more (5 quarters), it rose the next day 80% of the time, averaging +2.1%. This describes past reports; it is not a forecast.

How we calculate these numbers · CGON: 12 reported quarters, latest Nov 6, 2026. Information only, not investment advice.

Looking for more on CGON?

Price charts, forecast, fundamentals and risk pages for CGON are not on Tickzen yet. You can run a full stock analysis now.

Run the CGON Stock Analyzer